Localization of ion channels to lipid raft domains within the cardiovascular system

Trends in Cardiovascular Medicine

Volumn 14, Issue 2, 2004, Pages 37-42

  O'Connell, Kristen M S ^a   Martens, Jeffrey R ^b   Tamkun, Michael M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CHOLESTEROL; ION CHANNEL; POTASSIUM CHANNEL; SODIUM CHANNEL; SPHINGOLIPID;

CARDIOVASCULAR SYSTEM; CELLULAR DISTRIBUTION; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 1542508954     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2003.10.002     Document Type: Review

References (56)

1. Barouch L.A., Harrison R.W., Skaf M.W.et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature. 416(6878):2002;337-339.
2. Beardslee M.A., Laing J.G., Beyer E.C.et al. Rapid turnover of connexin43 in the adult rat heart. Circ Res. 83(6):1998;629-635.
3. Bers D.M. Cardiac excitation-contraction coupling. Nature. 415(6868):2002;198-205.
4. Brown D.A., Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell. 68(3):1992;533-544.
5. Brown D.A., London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol. 14:1998;111-136.
6. Cheng H., Wang S.Q. Calcium signaling between sarcolemmal calcium channels and ryanodine receptors in heart cells. Front Biosci. 7:2002;d1867-d1878.
7. Cohen A.W., Park D.S., Woodman S.E.et al. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol. 284(2):2003;C457-C474.
8. Couet J., Li S., Okamoto T.et al. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem. 272(10):1997;6525- 6533.
9. Cukovic D., Lu G.W., Wible B.et al. A discrete amino terminal domain of Kv1.5 and Kv1.4 potassium channels interacts with the spectrin repeats of alpha-actinin-2. FEBS Lett. 498(1):2001;87-92.
10. Darby P.J., Kwan C.Y., Daniel E.E. Caveolae from canine airway smooth muscle contain the necessary components for a role in Ca(2+) handling. Am J Physiol Lung Cell Mol Physiol. 279(6):2000;L1226-L1235.
11. Davare M.A., Avdonin V., Hall D.D.et al. A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2. Science. 293(5527):2001;98-101.
12. Deal K.K., England S.K., Tamkun M.M. Molecular physiology of cardiac potassium channels. Physiol Rev. 76(1):1996;49-67.
13. Drab M., Verkade P., Elger M.et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 293(5539):2001;2449-2452.
14. Edidin M. The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct. 32:2003;257-283.
15. Feron O., Dessy C., Opel D.J.et al. Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. J Biol Chem. 273(46):1998;30,249-30, 254.
16. Feron O., Han X., Kelly R.A. Muscarinic cholinergic signaling in cardiac myocytes: dynamic targeting of M2AChR to sarcolemmal caveolae and eNOS activation. Life Sci. 64(6-7):1999a;471-477.
17. Feron O., Zhao Y.Y., Kelly R.A. The ins and outs of caveolar signaling. m2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes. Ann NY Acad Sci. 874:1999b;11-19.
18. Galbiati F., Engelman J.A., Volonte D.et al. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities. J Biol Chem. 276(24):2001;21,425-21,433.
19. Godreau D., Vranckx R., Maguy A.et al. Expression, regulation and role of the MAGUK protein SAP-97 in human atrial myocardium. Cardiovasc Res. 56(3):2002;433-442.
20. Gomperts S.N. Clustering membrane proteins: it's all coming together with the PSD-95/SAP90 protein family. Cell. 84(5):1996;659-662.
21. Harder T., Simons K. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr Opin Cell Biol. 9(4):1997;534-542.
22. Hope H.R., Pike L.J. Phosphoinositides and phosphoinositide-utilizing enzymes in detergent-insoluble lipid domains. Mol Biol Cell. 7(6):1996;843-851.
23. Hulme J.T., Coppock E.A., Felipe A.et al. Oxygen sensitivity of cloned voltage-gated K(+) channels expressed in the pulmonary vasculature. Circ Res. 85(6):1999;489-497.
24. Jacobson K., Dietrich C. Looking at lipid rafts? Trends Cell Biol. 9(3):1999;87-91.
25. Janes P.W., Ley S.C., Magee A.I. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J Cell Biol. 147(2):1999;447-461.
26. Kamp T.J., Hell J.W. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res. 87(12):2000;1095-1102.
27. Kim E., Niethammer M., Rothschild A.et al. Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases. Nature. 378(6552):1995;85-88.
28. Lohn M., Furstenau M., Sagach V.et al. Ignition of calcium sparks in arterial and cardiac muscle through caveolae. Circ Res. 87(11):2000;1034-1039.
29. Lopez-Lopez J.R., Shacklock P.S., Balke C.W.et al. Local calcium transients triggered by single L-type calcium channel currents in cardiac cells. Science. 268(5213):1995;1042-1045.
30. Lu T., Lee H.C., Kabat J.A.et al. Modulation of rat cardiac sodium channel by the stimulatory G protein alpha subunit. J Physiol. 518(Pt 2):1999;371-384.
31. Marban E. Cardiac channelopathies. Nature. 415(6868):2002;213-218.
32. Martens J.R., Kwak Y.G., Tamkun M.M. Modulation of Kv channel alpha/beta subunit interactions. Trends Cardiovasc Med. 9(8):1999;253-258.
33. Martens J.R., Navarro-Polanco R., Coppock E.A.et al. Differential targeting of Shaker-like potassium channels to lipid rafts. J Biol Chem. 275(11):2000;7443-7446.
34. Martens J.R., Sakamoto N., Sullivan S.A.et al. Isoform-specific localization of voltage-gated K+ channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae. J Biol Chem. 276(11):2001;8409-8414.
35. Maruoka N.D., Steele D.F., Au B.P.et al. alpha-Actinin-2 couples to cardiac Kv1.5 channels, regulating current density and channel localization in HEK cells. FEBS Lett. 473(2):2000;188-194.
36. Marx S.O., Kurokawa J., Reiken S.et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science. 295(5554):2002;496-499.
37. Mason H.S., Latten M.J., Godoy L.D.et al. Modulation of Kv1.5 currents by protein kinase A, tyrosine kinase, and protein tyrosine phosphatase requires an intact cytoskeleton. Mol Pharmacol. 61(2):2002;285-293.
38. Mery P.F., Pavoine C., Belhassen L.et al. Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem. 268(35):1993;26,286-26,295.
39. Minetti C., Sotgia F., Bruno C.et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet. 18(4):1998;365-368.
40. Mundy D.I., Machleidt T., Ying Y.S.et al. Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton. J Cell Sci. 115(Pt 22):2002;4327-4339.
41. Murphy B.J., Rogers J., Perdichizzi A.P.et al. cAMP-dependent phosphorylation of two sites in the alpha subunit of the cardiac sodium channel. J Biol Chem. 271(46):1996;28,837-28,843.
42. Okamoto T., Schlegel A., Scherer P.E.et al. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem. 273(10):1998;5419-5422.
43. Ono K., Fozzard H.A., Hanck D.A. Mechanism of cAMP-dependent modulation of cardiac sodium channel current kinetics. Circ Res. 72(4):1993;807-815.
44. Park D.S., Woodman S.E., Schubert W.et al. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol. 160(6):2002;2207-2217.
45. Razani B., Engelman J.A., Wang X.B.et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem. 276(41):2001;38,121-38,138.
46. Razani B., Wang X.B., Engelman J.A.et al. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol. 22(7):2002;2329-2344.
47. Rybin V.O., Xu X., Lisanti M.P.et al. Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae: a mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem. 275(52):2000;41447-41457.
48. Schubert A.L., Schubert W., Spray D.C.et al. Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry. 41(18):2002;5754-5764.
49. Simons K., Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 1(1):2000;31-39.
50. Tiffany A.M., Manganas L.N., Kim E.et al. PSD-95 and SAP97 exhibit distinct mechanisms for regulating K(+) channel surface expression and clustering. J Cell Biol. 148(1):2000;147-158.
51. Topinka J.R., Bredt D.S. N-terminal palmitoylation of PSD-95 regulates association with cell membranes and interaction with K+ channel K(v)1.4. Neuron. 20(1):1998;125-134.
52. Wong W., Newell E.W., Jugloff D.G.et al. Cell surface targeting and clustering interactions between heterologously expressed PSD-95 and the Shal voltage-gated potassium channel, Kv4.2. J Biol Chem. 277(23):2002;20,423-20,430.
53. Yarbrough T.L., Lu T., Lee H.C.et al. Localization of cardiac sodium channels in caveolin-rich membrane domains: regulation of sodium current amplitude. Circ Res. 90(4):2002;443-449.
54. Zajchowski L.D., Robbins S.M. Lipid rafts and little caves. Compartmentalized signalling in membrane microdomains. Eur J Biochem. 269(3):2002;737-752.
55. Zhao Y.Y., Liu Y., Stan R.V.et al. Defects in caveolin - 1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci USA. 99(17):2002;11,375-11,380.
56. Zhou Z., Gong Q., Epstein M.L.et al. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects. J Biol Chem. 273(33):1998;21,061-21,066.